benedict carey robert gebeloffapril victoria toline would hunch kitchen table steady hands draw bead liquid vial small dropper delicate operation become daily routine extracting ever tinier doses antidepressant taken three years desperately trying quit basically dealing dizziness confusion fatigue symptoms withdrawal said ms toline tacoma wash took nine months wean drug zoloft taking increasingly smaller doses finish college degree said feeling well enough try enter society go back work long term use antidepressants surging united states according new analysis federal data new york times million americans taking medications least five years rate almost doubled since tripled since nearly million adults like ms toline antidepressants least two years percent increase since drugs helped millions people ease depression anxiety widely regarded milestones psychiatric treatment many perhaps people stop medications without significant trouble rise longtime use also result unanticipated growing problem many try quit say cannot withdrawal symptoms never warned scientists long ago anticipated patients might experience withdrawal symptoms tried stop called discontinuation syndrome yet withdrawal never focus drug makers government regulators felt antidepressants could addictive far good harm drugs initially approved short term use following studies typically lasting two months even today little data effects people taking years although millions users expanding use antidepressants issue united states across much developed world long term prescriptions rise prescription rates doubled past decade britain health officials january began nationwide review prescription drug dependence withdrawal new zealand prescriptions also historic highs survey long term users found withdrawal common complaint cited three quarters long term users yet medical profession good answer people struggling stop taking drugs scientifically backed guidelines means determine highest risk way tailor appropriate strategies individuals people essentially parked drugs convenience sake difficult tackle issue taking said dr anthony kendrick professor primary care university southampton britain government funding developing online telephone support help practitioners patients really putting many people antidepressants long term know good whether able come said antidepressants originally considered short term treatment episodic mood problems taken six nine months enough get crisis later studies suggested maintenance therapy longer term often open ended use could prevent return depression patients trials rarely lasted two years drug approved physicians united states wide latitude prescribe see fit lack long term data prevent doctors placing tens millions americans antidepressants indefinitely people put drugs primary care brief visit without clear symptoms clinical depression said dr allen frances professor emeritus psychiatry duke university usually improvement often based passage time placebo effect patient doctor know give antidepressant credit deserve reluctant stop appears winner useless prescription may continued years lifetime times analyzed data gathered since part national health nutrition examination survey million adults took antidepressants million survey adults women whites likely take antidepressants younger adults men minorities usage increasing older adults across demographic spectrum nearly percent american adults taken prescription antidepressants least five years april white women account one fifth adult population account percent antidepressant users percent analysis found older white women account percent antidepressants long term older white women account percent adults used antidepressants least five years april see number long term users piling year year said dr dr mark olfson professor psychiatry columbia university dr olfson dr ramin mojtabai professor psychiatry johns hopkins university assisted times analysis still clear everyone open ended prescription come doctors agree subset users benefit lifetime prescription disagree large group dr peter kramer psychiatrist author several books antidepressants said generally works wean patients mild moderate depression medication report better cultural question much depression people live treatments give many better quality life dr kramer said think question decided advance antidepressants harmless commonly cause emotional numbing sexual problems like lack desire erectile dysfunction weight gain long term users report interviews creeping unease hard measure daily pill popping leaves doubting resilience say come place least west seems every person depressed medication said edward shorter historian psychiatry university toronto wonder says culture patients try stop taking drugs often say cannot recent survey long term users psychiatric drugs commonly antidepressants half wound prescriptions rated withdrawal severe nearly half tried quit could symptoms another study longtime antidepressant users withdrawal symptoms reported almost half said felt addicted antidepressants many critical lack information given prescribers regard withdrawal authors concluded many also expressed disappointment frustration lack support available managing withdrawal drug manufacturers deny patients suffer harsh symptoms trying wean antidepressants likelihood developing discontinuation syndrome varies individuals treatment dosage prescribed said thomas biegi spokesman pfizer maker antidepressants like zoloft effexor urged patients work doctors taper wean taking shrinking doses said company could provide specific withdrawal rates drugmaker eli lilly referring two popular antidepressants said statement company remains committed prozac cymbalta safety benefits repeatedly affirmed u food drug administration company declined say common withdrawal symptoms far back mid leading psychiatrists recognized withdrawal potential problem patients taking modern antidepressants conference phoenix sponsored drug maker eli lilly panel academic psychiatrists produced lengthy report detailing symptoms like balance problems insomnia anxiety went away pills restarted interested sharing experience long term prescriptions antidepressants sleeping pills drugs anxiety please fill form may publish selection responses words left characters left words left words left submissions may selected publication select intend use first last name words left publish used journalists need contact characters left characters left city state city country submitting us promising content original plagiarize anyone infringe copyright trademark violate anyone rights libelous otherwise unlawful misleading agreeing use submission manner media new york times shall right authorize third parties agree terms service thank submission soon topic faded scientific literature government regulators focus symptoms seeing rampant depression larger problem concentrating recurrent depression said dr robert temple deputy director clinical science f center drug evaluation research people heads went roof withdrawal think would seen drug makers little incentive mount costly studies best quit products federal funding filled research gap please verify youre robot clicking box invalid email address please enter must select newsletter subscribe view new york times newsletters result drugs labels doctors many patients rely provide little guidance ending prescription safely following adverse events reported incidence percent greater reads label cymbalta leading antidepressant lists headaches fatigue insomnia among reactions patients trying stop studies antidepressant withdrawal published suggest harder get medications others due differences drugs half life time takes body clear medication pills stopped brands relatively short half life like effexor paxil appear cause withdrawal symptoms quickly stay system longer like prozac one earliest published withdrawal studies researchers eli lilly people taking zoloft paxil prozac stop pills abruptly week half paxil experienced serious dizziness percent suffered confusion percent insomnia among patients stopped taking zoloft percent severe irritability percent experienced dizziness percent fatigue symptoms appeared soon people taken drugs resolved resumed taking pills prozac contrast experienced initial spike symptoms stopped result surprising takes prozac several weeks wash body entirely one week interruption test withdrawal study cymbalta another eli lilly drug people withdrawal experienced two three symptoms average common dizziness nausea headache paresthesia electric shock sensations brain many people call brain zaps symptoms lasted longer two weeks truth state science absolutely inadequate said dr derelie mangin professor department family medicine mcmaster university hamilton ontario enough information antidepressant withdrawal entails design proper tapering approaches interviews dozens people experienced antidepressant withdrawal recounted similar stories drugs often relieved mood problems first year clear whether medication effect yet quitting far harder stranger expected took year come completely year said dr tom stockmann psychiatrist east london experienced lightheadedness confusion vertigo brain zaps stopped taking cymbalta months wind prescription safely began opening capsules removing beads drug day order taper way decided knew people experienced withdrawal reactions dr stockmann said idea hard would robin hempel mother four lives near concord n h began taking antidepressant paxil years ago severe premenstrual syndrome recommendation gynecologist said oh little pill going change life ms hempel said well ever drug blunted pms symptoms said also caused gain pounds nine months quitting nearly impossible first doctor tapered quickly said succeeded last attempt tapering months milligrams five milligrams finally way particles dust bedridden three weeks severe dizziness nausea crying spells said told risks trying come drug never would started ms hempel said year half stopping still problems right creativity energy robin gone least pressing questions antidepressant withdrawal soon answer dr mangin mcmaster university led research team new zealand recently completed first rigorous long term trial withdrawal team recruited people three cities taking prozac long term interested tapering two thirds group drug two years third five years team randomly assigned participants one two regimens half tapered slowly receiving capsule day period month longer contained progressively lower amounts active drug half believed tapering got capsules fact maintained regular dosage researchers followed groups year half still working data findings published coming months one thing already clear effort clinical experience dr mangin said people symptoms severe could bear stop taking drug even slow taper drug relatively long half life people significant withdrawal symptoms restart drug said people able quit following doctor advice turning method called microtapering making tiny reductions long period time nine months year two years whatever takes tapering rates given doctors often way way fast said laura delano severe symptoms trying get several psychiatric drugs created website withdrawal project provides resources psychiatric drug withdrawal including guide tapering hardly one bewildered scarcity good medical advice unwinding prescriptions become common taken long long time get anyone pay attention issue take seriously said luke montagu media entrepreneur co founder london based council evidence based psychiatry pushed britain review prescription drug addiction dependence got huge parallel community emerged largely online people supporting though withdrawal developing best practices largely without help doctors said dr stockmann psychiatrist east london entirely convinced withdrawal serious issue went microtapering strategy finally worked really significant moment recalled walking near house past forest suddenly realized could feel full range emotions birds louder colors vivid happy seen lots people patients believed taken seriously complained added stop follow nythealth twitter sign science times newsletter version article appears print april page new york edition headline murky perils quitting antidepressants years use order reprints todays paper subscribe interested feedback page tell us think go home page